Verona Pharma Completes Enrollment in ENHANCE-1 48-week Subset
ENHANCE-2 Screening Complete with Full Enrollment Expected in January 2022 ENHANCE Phase 3 Program on…
ENHANCE-2 Screening Complete with Full Enrollment Expected in January 2022 ENHANCE Phase 3 Program on…
Press Release Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030 Patent coverage for…
Oslo, Norway and Seoul, South Korea 5 January, 2022 – PCI Biotech (OSE: PCIB), a…
Clover expects to recruit hundreds of new hires in the area to support preclinical development,…
Verizon accelerates wireless broadband rollout around the nation with 5G Home Internet and 5G Business…
For media: we have b-roll, pictures, and additional information on our emergency response equipment available…
What you need to know: BlueJeans Meetings now comes preloaded on Glass Enterprise Edition 2…
HAMILTON, Ontario, Jan. 05, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF…
AUSTIN, Texas, Jan. 04, 2022 (GLOBE NEWSWIRE) — ProjectManager, a leading project and work management…
Refreshed HERE WeGo HERE WeGo navigation app More partner-enabled options for ride-hailing, hotel booking, ticketing,…
HERE launches Indoor Map as a service with SBB AG as first customer Swiss railway…
Developers can now remove cloud migration blockers right from Visual Studio Code The CAST Highlight…
DENVER, Jan. 04, 2022 (GLOBE NEWSWIRE) — Axcient, a leader in business availability software for…
NetSfere won a place on the £250m NHS SBS Patient/Citizen Communication & Engagement Solutions Framework…
Santa Monica, Jan. 04, 2022 (GLOBE NEWSWIRE) — The holidays are here, and Americans are…
As payments drive the customer experience, digital and mobile will dominate BURLINGTON, Mass., Jan. 04,…
Maps Figure 1. Copenhagen Minerals Inc. Exploration Licenses; Figure 2. Copenhagen Minerals Inc. Prospecting License…
HONG KONG, Jan 5, 2022 – (ACN Newswire) – Nissin Foods Company Limited (“Nissin Foods”,…
HONG KONG, Jan 5, 2022 – (ACN Newswire) – Yeahka Limited (“Yeahka” or the “Company”)…
LAUSANNE, Switzerland, Jan 5, 2022 – (ACN Newswire) – Oculis S.A. (“Oculis”), a late-stage biopharmaceutical…